Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Apperley

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Leukemia|February 10, 2006
The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinibJ S Khorashad, M Anand, D Marin, et al.
Blood|December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaF Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxisC Craddock, R M Szydlo, F Dazzi, et al.
Bone Marrow Transplantation|February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patientsD O'Shea, C Giles, E Terpos, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
British Journal of Haematology|February 23, 1999
CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcomeD Gupta, A Bybee, F Cooke, et al.
British Journal of Haematology|September 13, 2001
T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvementE Olavarria, F Child, A Woolford, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Leukemia|February 10, 2006
The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinibJ S Khorashad, M Anand, D Marin, et al.
Blood|December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaF Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxisC Craddock, R M Szydlo, F Dazzi, et al.
Bone Marrow Transplantation|February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patientsD O'Shea, C Giles, E Terpos, et al.
Leukemia|May 10, 2000
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant RegistryE F Posthuma, J H Falkenburg, J F Apperley, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
British Journal of Haematology|February 23, 1999
CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcomeD Gupta, A Bybee, F Cooke, et al.
British Journal of Haematology|September 13, 2001
T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvementE Olavarria, F Child, A Woolford, et al.
Pageof 14